Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: An open labeled randomized comparative trial
Background : Melasma is a common acquired cause of facial hyperpigmentation with no definitive therapy. Tranexamic acid, a plasmin inhibitor, has demonstrated depigmenting properties and combining this oral drug with other modalities of treatment has shown promising results. Objectives : To compare...
Main Authors: | Tanmay Padhi, Swetalina Pradhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: |
Similar Items
-
Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma
by: Pazyar N, et al.
Published: (2019-02-01) -
Comparative study of efficacy of intradermal tranexamic acid versus topical tranexamic acid versus triple combination in melasma
by: Shruti S Patil, et al.
Published: (2019-01-01) -
Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin
by: Ahmad Nasrollahi S, et al.
Published: (2019-06-01) -
A randomized controlled study comparing the efficacy of topical 5% tranexamic acid solution versus 3% hydroquinone cream in melasma
by: Manasa S Janney, et al.
Published: (2019-01-01) -
Tranexamic acid in melasma: a review
by: Amrit Kaur, et al.
Published: (2020-01-01)